Literature DB >> 9076821

Fifteen years of experience with Vero-produced enhanced potency inactivated poliovirus vaccine.

E Vidor1, C Meschievitz, S Plotkin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9076821     DOI: 10.1097/00006454-199703000-00011

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  12 in total

Review 1.  Childhood immunisation today.

Authors:  J Eskola
Journal:  Drugs       Date:  1998-06       Impact factor: 9.546

2.  Preeradication vaccine policy options for poliovirus infection and disease control.

Authors:  Kimberly M Thompson; Mark A Pallansch; Radboud J Duintjer Tebbens; Steve G Wassilak; Jong-Hoon Kim; Stephen L Cochi
Journal:  Risk Anal       Date:  2013-03-05       Impact factor: 4.000

3.  Controversies in polio immunization.

Authors:  Naveen Thacker; Niranjan Shendurnikar
Journal:  Indian J Pediatr       Date:  2003-07       Impact factor: 1.967

4.  Advax-CpG Adjuvant Provides Antigen Dose-Sparing and Enhanced Immunogenicity for Inactivated Poliomyelitis Virus Vaccines.

Authors:  Yoshikazu Honda-Okubo; Jeremy Baldwin; Nikolai Petrovsky
Journal:  Pathogens       Date:  2021-04-21

5.  Immunogenicity and safety of a novel monovalent high-dose inactivated poliovirus type 2 vaccine in infants: a comparative, observer-blind, randomised, controlled trial.

Authors:  Xavier Sáez-Llorens; Ralf Clemens; Geert Leroux-Roels; José Jimeno; Sue Ann Costa Clemens; William C Weldon; M Steven Oberste; Natanael Molina; Ananda S Bandyopadhyay
Journal:  Lancet Infect Dis       Date:  2015-12-21       Impact factor: 71.421

6.  The immunogenicity and safety of a new combined diphtheria, tetanus and poliomyelitis booster vaccine (Td-eIPV).

Authors:  P Laroche; M Barrand; S C Wood; K Van Hasbrouck; J Lang; E Harzer; L Hessel
Journal:  Infection       Date:  1999 Jan-Feb       Impact factor: 7.455

7.  Neurovirulent vaccine-derived polioviruses in sewage from highly immune populations.

Authors:  Lester M Shulman; Yossi Manor; Danit Sofer; Rachel Handsher; Tiberio Swartz; Francis Delpeyroux; Ella Mendelson
Journal:  PLoS One       Date:  2006-12-20       Impact factor: 3.240

Review 8.  Immunogenicity and effectiveness of routine immunization with 1 or 2 doses of inactivated poliovirus vaccine: systematic review and meta-analysis.

Authors:  Nicholas C Grassly
Journal:  J Infect Dis       Date:  2014-03-14       Impact factor: 5.226

9.  Single PA mutation as a high yield determinant of avian influenza vaccines.

Authors:  Ilseob Lee; Jin Il Kim; Sehee Park; Joon-Yong Bae; Kirim Yoo; Soo-Hyeon Yun; Joo-Yeon Lee; Kisoon Kim; Chun Kang; Man-Seong Park
Journal:  Sci Rep       Date:  2017-01-13       Impact factor: 4.379

10.  Recombinant Infectious Bronchitis Viruses Expressing Chimeric Spike Glycoproteins Induce Partial Protective Immunity against Homologous Challenge despite Limited Replication In Vivo.

Authors:  Erica Bickerton; Lonneke Vervelde; Samantha Ellis; Sarah Keep; Paul Britton; Sjaak de Wit
Journal:  J Virol       Date:  2018-11-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.